Redwood City, CA · Founded 2012 · Privately Held (backing)
Developer of small molecule antivirals designed to improve health outcomes for patients suffering from diseases caused by HPV and other viruses. Antiva Biosciences is based in Redwood City, CA and was founded in 2012. Its last known valuation is $123 million. It has raised $145 million across 4 recorded rounds; the latest was a $38.5 million early-stage round in Apr 2023.
Last price · $/share
—
Implied valuation
$123.0M
Total raised
$144.8M
Last round
Early Stage VC
Apr 2023
Cap table — not yet on record
Antiva Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Antiva Biosciences with a free account
·The complete investor list: 21 names
·Watch Antiva Biosciences: the Monday email on marks, rounds and moves
Where does Antiva Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Antiva Biosciences's 4 recorded funding rounds.
Antiva Biosciences Cap Table & Share Classes | Premier Alternatives
